 GSK Break to the downside coming this week since an hedge order came in for 4/19 exp.
GSK Break to the downside coming this week since an hedge order came in for 4/19 exp.
Entry below $40.51
Trade becomes invalid on any gap and go or around the $40.98 area
 GSK jemperil clinical trial forecasted to be complete by end of June. It treats endometrial cancer
GSK jemperil clinical trial forecasted to be complete by end of June. It treats endometrial cancer